Literature DB >> 18508904

Reovirus serotypes elicit distinctive patterns of recall immunity in humans.

Renée N Douville1, Ruey-Chyi Su, Kevin M Coombs, F Estelle R Simons, Kent T Hayglass.   

Abstract

Mammalian orthoreoviruses (reoviruses) are ubiquitous viral agents that infect cells in respiratory and enteric tracts. The frequency and nature of human cellular immunoregulatory responses against reovirus are unknown. Here we establish systems to detect and quantify reovirus-induced cytokine and chemokine recall responses using primary cultures of virus-infected peripheral blood mononuclear cells (PBMC) and two widely used reovirus serotypes, type 1 Lang (T1L) and type 3 Dearing (T3D) reexposure in vitro. In cultures from 44 healthy adults, reovirus induced exceptionally strong CD4 and CD8 T-cell-dependent gamma interferon (IFN-gamma) recall responses concomitant with intense interleukin 10 (IL-10) production. These responses were elicited independently of viral replication. Surprisingly, paired analyses of subject responses to these two common serotypes revealed that while both elicit intense Th1-dominated immunity, median T3D-driven responses were 2.2-fold weaker (P = 0.0004) than those elicited by T1L. Recall responses evoked by these viral serotypes differed markedly in their mechanism of regulation. T3D IL-10 and IFN-gamma responses were CD4 and CD8 dependent and blocked by interfering with CD86 costimulation but were CD80 independent. T1L responses were consistently CD28 and CD80/86 independent. Thus, despite extensive genetic and morphological similarities between reovirus serotypes, the nature and intensity of the human recall responses as well as the control mechanisms regulating them are clearly distinct.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508904      PMCID: PMC2493337          DOI: 10.1128/JVI.00464-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Reovirus as a novel oncolytic agent.

Authors:  K L Norman; P W Lee
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 2.  Costimulation in antiviral immunity: differential requirements for CD4(+) and CD8(+) T cell responses.

Authors:  J K Whitmire; R Ahmed
Journal:  Curr Opin Immunol       Date:  2000-08       Impact factor: 7.486

Review 3.  Mucosal T cell response to reovirus.

Authors:  D Chen; D H Rubin
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  Myocarditis associated with reovirus infection.

Authors:  F Terheggen; E Benedikz; P H J Frissen; K Brinkman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-01       Impact factor: 3.267

5.  Ultrasensitive ELISA for measurement of human cytokine responses in primary culture.

Authors:  William P Stefura; J Darren Campbell; Renée Douville; Monique J Stinson; F Estelle Simons; Allan B Becker; Kent T HayGlass
Journal:  Methods Mol Med       Date:  2008

6.  B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha.

Authors:  M M Swallow; J J Wallin; W C Sha
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

7.  Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responses.

Authors:  V Blazevic; C M Trubey; G M Shearer
Journal:  J Clin Immunol       Date:  2001-07       Impact factor: 8.317

8.  A comparative analysis of freon substitutes in the purification of reovirus and calicivirus.

Authors:  I I Mendez; L L Hermann; P R Hazelton; K M Coombs
Journal:  J Virol Methods       Date:  2000-10       Impact factor: 2.014

9.  Histologic and immunologic observations of viral-induced rhinosinusitis in the mouse.

Authors:  Hassan H Ramadan; Robert B Meek; G Stephen Dawson; George A Spirou; Christopher F Cuff; Albert S Berrebi
Journal:  Am J Rhinol       Date:  2002 Jan-Feb

10.  Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation.

Authors:  Chandini M Thirukkumaran; Joanne M Luider; Douglas A Stewart; Tina Cheng; Sasha M Lupichuk; Michael J Nodwell; James A Russell; Iwona A Auer; Donald G Morris
Journal:  Blood       Date:  2003-03-13       Impact factor: 22.113

View more
  5 in total

1.  In vitro anti-reovirus activity of kuraridin isolated from Sophora flavescens against viral replication and hemagglutination.

Authors:  Hyung-Jun Kwon; Jae-Ho Jeong; Seung Woong Lee; Young Bae Ryu; Hyung Jae Jeong; Kyungsook Jung; Jae Sung Lim; Kyoung-Oh Cho; Woo Song Lee; Mun-Chual Rho; Su-Jin Park
Journal:  J Pharmacol Sci       Date:  2015-04-30       Impact factor: 3.337

2.  Elevated antigen-driven IL-9 responses are prominent in peanut allergic humans.

Authors:  Jungang Xie; Larisa C Lotoski; Rishma Chooniedass; Ruey-Chyi Su; F Estelle R Simons; Joel Liem; Allan B Becker; Jude Uzonna; Kent T HayGlass
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

3.  Bat mammalian orthoreoviruses cause severe pneumonia in mice.

Authors:  Ren-Di Jiang; Bei Li; Xiang-Ling Liu; Mei-Qin Liu; Jing Chen; Dong-Sheng Luo; Bing-Jie Hu; Wei Zhang; Shi-Yue Li; Xing-Lou Yang; Zheng-Li Shi
Journal:  Virology       Date:  2020-06-22       Impact factor: 3.616

Review 4.  Rethinking the Significance of Reovirus in Water and Wastewater.

Authors:  Walter Q Betancourt; Charles P Gerba
Journal:  Food Environ Virol       Date:  2016-06-18       Impact factor: 2.778

Review 5.  Past, Present and Future of Oncolytic Reovirus.

Authors:  Louise Müller; Robert Berkeley; Tyler Barr; Elizabeth Ilett; Fiona Errington-Mais
Journal:  Cancers (Basel)       Date:  2020-10-31       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.